TP ICAP Financials
TCAP Stock | 310.00 1.50 0.49% |
Operating Margin | PE Ratio 14.7619 | Profit Margin | Payout Ratio 0.0161 | EPS Estimate Current Year 0.3178 |
TCAP | Select Account or Indicator |
Please note, the imprecision that can be found in TP ICAP's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of TP ICAP Group. Check TP ICAP's Beneish M Score to see the likelihood of TP ICAP's management manipulating its earnings.
TP ICAP Stock Summary
TP ICAP competes with Odyssean Investment, X FAB, Auto Trader, New Residential, and Chrysalis Investments. TP ICAP is entity of United Kingdom. It is traded as Stock on LSE exchange.Foreign Associate | USA |
Specialization | Financial Services, Financial Services |
Instrument | UK Stock View All |
Exchange | London Exchange |
ISIN | JE00BMDZN391 |
Business Address | 22 Grenville Street, |
Sector | Capital Markets |
Industry | Financials |
Benchmark | Dow Jones Industrial |
Website | www.tpicap.com |
Phone | 44 15 3467 6720 |
You should never invest in TP ICAP without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of TCAP Stock, because this is throwing your money away. Analyzing the key information contained in TP ICAP's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
TP ICAP Key Financial Ratios
There are many critical financial ratios that TP ICAP's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that TP ICAP Group reports annually and quarterly.Revenue | 2.25 B | ||||
Gross Profit | 2.19 B | ||||
EBITDA | 378 M | ||||
Net Income | 167 M | ||||
Total Asset | 6.45 B |
TP ICAP Key Balance Sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 72.7B | 5.5B | 5.9B | 6.2B | 6.4B | 6.1B | |
Other Current Liab | (148M) | (216M) | (150M) | 2.9B | 3.2B | 3.4B | |
Other Liab | 132M | 127M | 199M | 179M | 205.9M | 188.2M | |
Net Debt | 281M | 360M | 185M | 59M | (324M) | (307.8M) | |
Retained Earnings | 1.4B | 2.8B | 2.8B | 2.8B | 2.9B | 3.1B | |
Accounts Payable | 22M | 17M | 24M | 40M | 39M | 37.1M | |
Cash | 656M | 784M | 888M | 1.0B | 1.1B | 1.1B | |
Other Assets | 28M | 62M | 67M | 6.2B | (3.3B) | (3.2B) | |
Long Term Debt | 679M | 779M | 785M | 744M | 855.6M | 898.4M | |
Good Will | 989M | 1.2B | 1.2B | 1.2B | 1.2B | 646.7M | |
Other Current Assets | 1.6B | 2.1B | 2.2B | (4.0B) | 2.8B | 2.7B | |
Total Liab | 71.0B | 3.5B | 3.7B | 4.1B | 4.4B | 4.2B | |
Total Current Assets | 70.8B | 3.1B | 3.5B | 1.0B | 4.4B | 4.2B | |
Short Term Debt | 98M | 149M | 67M | 121M | 9M | 8.6M | |
Intangible Assets | 532M | 673M | 645M | 559M | 542M | 313.0M | |
Net Receivables | 1.5B | 2.0B | 2.1B | 2.2B | 364M | 345.8M | |
Net Tangible Assets | 140M | 158M | 108M | 266M | 239.4M | 167.9M | |
Short Long Term Debt | 144M | 11M | 46M | 77M | 9M | 8.6M |
TP ICAP Key Income Statement Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Interest Expense | 49M | 54M | 41M | 63M | 72.5M | 76.1M | |
Total Revenue | 1.8B | 1.9B | 2.1B | 2.2B | 2.3B | 1.2B | |
Gross Profit | 725M | 792M | 599M | 762M | 793M | 795.8M | |
Operating Income | 178M | 140M | 163M | 244M | 254M | 266.7M | |
Ebit | 208M | 140M | 166M | 159M | 264M | 277.2M | |
Ebitda | 303M | 268M | 293M | 276M | 378M | 396.9M | |
Income Before Tax | 129M | 24M | 113M | 96M | 233M | 244.7M | |
Net Income | 96M | 1M | 77M | 74M | 167M | 175.4M | |
Income Tax Expense | 40M | 48M | 23M | 36M | 63M | 66.2M | |
Minority Interest | 16M | 18M | 19M | (3M) | (2M) | (2.9M) | |
Cost Of Revenue | 1.1B | 1.1B | 1.5B | 1.4B | 1.5B | 789.3M | |
Research Development | 184M | 208M | 237M | 220M | 218M | 177.3M | |
Tax Provision | 40M | 48M | 23M | 36M | 63M | 37.0M |
TP ICAP Key Cash Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Change In Cash | (27M) | 118M | 121M | 131M | 47M | 46.5M | |
Free Cash Flow | 91M | 53M | 271M | 215M | 344M | 361.2M | |
Depreciation | 95M | 128M | 127M | 117M | 114M | 119.7M | |
Capital Expenditures | 33M | 53M | 58M | 12M | 9M | 8.6M | |
Net Income | 178M | 97M | 163M | 74M | 167M | 106.2M | |
End Period Cash Flow | 649M | 767M | 888M | 1.0B | 1.1B | 1.1B | |
Investments | 17M | 15M | (78M) | 31M | (30M) | (28.5M) | |
Net Borrowings | 25M | 4M | 43M | (76M) | (87.4M) | (83.0M) | |
Change To Netincome | (2M) | (10M) | 31M | 5M | 5.8M | 5.5M |
TCAP Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining TP ICAP's current stock value. Our valuation model uses many indicators to compare TP ICAP value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across TP ICAP competition to find correlations between indicators driving TP ICAP's intrinsic value. More Info.TP ICAP Group is rated second in return on equity category among its peers. It is currently regarded as top stock in return on asset category among its peers reporting about 0.33 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for TP ICAP Group is roughly 3.05 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the TP ICAP's earnings, one of the primary drivers of an investment's value.TP ICAP Group Systematic Risk
TP ICAP's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. TP ICAP volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty with a total number of output elements of thirty-one. The Beta measures systematic risk based on how returns on TP ICAP Group correlated with the market. If Beta is less than 0 TP ICAP generally moves in the opposite direction as compared to the market. If TP ICAP Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one TP ICAP Group is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of TP ICAP is generally in the same direction as the market. If Beta > 1 TP ICAP moves generally in the same direction as, but more than the movement of the benchmark.
TP ICAP Group Total Assets Over Time
TP ICAP July 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of TP ICAP help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of TP ICAP Group. We use our internally-developed statistical techniques to arrive at the intrinsic value of TP ICAP Group based on widely used predictive technical indicators. In general, we focus on analyzing TCAP Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build TP ICAP's daily price indicators and compare them against related drivers.
Downside Deviation | 1.19 | |||
Information Ratio | 0.1765 | |||
Maximum Drawdown | 6.18 | |||
Value At Risk | (1.33) | |||
Potential Upside | 2.3 |
Additional Tools for TCAP Stock Analysis
When running TP ICAP's price analysis, check to measure TP ICAP's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy TP ICAP is operating at the current time. Most of TP ICAP's value examination focuses on studying past and present price action to predict the probability of TP ICAP's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move TP ICAP's price. Additionally, you may evaluate how the addition of TP ICAP to your portfolios can decrease your overall portfolio volatility.